Shanghai Kinetic Medical Co., Ltd

SZSE:300326 Stock Report

Market Cap: CN¥3.8b

Shanghai Kinetic Medical Future Growth

Future criteria checks 5/6

Shanghai Kinetic Medical is forecast to grow earnings and revenue by 40.5% and 21.6% per annum respectively. EPS is expected to grow by 39.6% per annum. Return on equity is forecast to be 5.6% in 3 years.

Key information

40.5%

Earnings growth rate

39.6%

EPS growth rate

Medical Equipment earnings growth27.5%
Revenue growth rate21.6%
Future return on equity5.6%
Analyst coverage

Low

Last updated24 Apr 2024

Recent future growth updates

Recent updates

Shanghai Kinetic Medical Co., Ltd's (SZSE:300326) Shares Leap 46% Yet They're Still Not Telling The Full Story

Oct 08
Shanghai Kinetic Medical Co., Ltd's (SZSE:300326) Shares Leap 46% Yet They're Still Not Telling The Full Story

Shanghai Kinetic Medical's (SZSE:300326) Solid Earnings May Rest On Weak Foundations

May 02
Shanghai Kinetic Medical's (SZSE:300326) Solid Earnings May Rest On Weak Foundations

Why Investors Shouldn't Be Surprised By Shanghai Kinetic Medical Co., Ltd's (SZSE:300326) Low P/S

Apr 17
Why Investors Shouldn't Be Surprised By Shanghai Kinetic Medical Co., Ltd's (SZSE:300326) Low P/S

Earnings and Revenue Growth Forecasts

SZSE:300326 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,626175N/A1241
12/31/20251,359147N/A1101
12/31/20241,132122N/A1361
9/30/202497039120197N/A
6/30/20249092865135N/A
3/31/202490849119178N/A
12/31/2023956113220274N/A
9/30/2023974-89104160N/A
6/30/20231,087-39226271N/A
3/31/20231,143-22209251N/A
1/1/20231,166-21195237N/A
9/30/20221,224159316353N/A
6/30/20221,235181361407N/A
3/31/20221,280183347395N/A
1/1/20221,269162329378N/A
9/30/20211,242-124323368N/A
6/30/20211,212-132218259N/A
3/31/20211,141-122339374N/A
12/31/20201,062-127255285N/A
9/30/20201,155277351379N/A
6/30/20201,140268369397N/A
3/31/20201,159280197231N/A
12/31/20191,222302215256N/A
9/30/20191,10452570111N/A
6/30/20191,04350557101N/A
3/31/20199884865088N/A
12/31/20189314635795N/A
9/30/2018918202202232N/A
6/30/2018893211N/A185N/A
3/31/2018879206N/A156N/A
12/31/2017802195N/A147N/A
9/30/2017707188N/A66N/A
6/30/2017654188N/A51N/A
3/31/2017594172N/A158N/A
12/31/2016551159N/A130N/A
9/30/2016552150N/A132N/A
6/30/2016522117N/A139N/A
3/31/201649498N/A75N/A
12/31/2015463121N/A111N/A
9/30/2015420116N/A59N/A
6/30/2015342106N/A67N/A
3/31/201526895N/A59N/A
12/31/201422262N/A71N/A
9/30/201417465N/A32N/A
6/30/201415561N/A34N/A
3/31/201413464N/A61N/A
12/31/201312764N/A33N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300326's forecast earnings growth (40.5% per year) is above the savings rate (2.9%).

Earnings vs Market: 300326's earnings (40.5% per year) are forecast to grow faster than the CN market (25.7% per year).

High Growth Earnings: 300326's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300326's revenue (21.6% per year) is forecast to grow faster than the CN market (14% per year).

High Growth Revenue: 300326's revenue (21.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300326's Return on Equity is forecast to be low in 3 years time (5.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y